Integrin αvβ3 as a therapeutic target for blocking tumor-induced angiogenesis

Current Drug Targets

Volumn 4, Issue 2, 2003, Pages 123-131

  Kumar, C Chandra ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; BETA3 INTEGRIN; BEVACIZUMAB; CILENGITIDE; ENDOSTATIN; INTEGRIN RECEPTOR; L 74815; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; PROTEIN KINASE INHIBITOR; SB 223245; SCH 22153; THROMBOSPONDIN; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; BONE METASTASIS; BRAIN TUMOR; BREAST CANCER; BREAST TUMOR; CHORIOALLANTOIS; COLORECTAL CANCER; DRUG TARGETING; EXPERIMENTAL MODEL; GROWTH INHIBITION; HUMAN; INHIBITION KINETICS; KAPOSI SARCOMA; LARYNX CARCINOMA; LEYDIG CELL TUMOR; LUNG CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; MYELOMA; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; TUMOR GROWTH; TUMOR VASCULARIZATION; ANIMAL; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; METABOLISM; METHODOLOGY; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY;

ANGIOGENESIS INHIBITORS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; INTEGRIN ALPHAVBETA3; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0037318003     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033346830     Document Type: Review

References (69)

1. Pytela, R., Pierschbacher, M.D and Rouslahti, E. (1985) Proc. Natl. Acad. Sci. USA 82, 5766-5770.
2. Ruoslahti, E. (1996) Ann. Rev. Cell Dev. Biol. 12, 697-715.
3. Hynes, R. (1999) Trends Cell Biol. 12, 33-37.
4. Kumar, C. C. (1998) Oncogene 17, 1365-1373.
5. Miyamoto, S., Teramoto, H., Cosco, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. K. and Yamada, K. M. (1995) J. Cell Biol. 131, 791-805.
6. Burridge, K., Fath, K., Kelly, G., Nuckolls, G. and Turner, C. (1998) Ann. Rev. Cell Biol. 4, 487-525.
7. Frisch, S. M. and Francis, H. J. (1994) J. Cell Biol. 124, 619-626.
8. Meredith, J. E., Fazeli, B. and Schwartz, M. A. (1993) Mol. Biol. Cell 4, 953-961.
9. Frisch, S. M. and Ruoslahti, E. (1997) Curr. Opin. Cell Biol. 9, 701-706.
10. Re, F., Zanetti, A., Sironi, M., Polentarutti, E., Lanfrancone, L., Dejana, E. and Cololta, F. (1994) J. Cell Biol. 127, 537-546.
11. Giancotti, F. G. and Ruoslahti, E. (1999) Science 285, 1028-1032.
12. Folkman, J. (1992) Seminars in Cancer Biology 3, 65-71.
13. Folkman, J. (1995) Nature Med 1, 27-30.
14. Brooks, P. C., Clark, R. A. F. and Cheresh, D. A. (1994) Science 264, 569-571.
15. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hiu, T., Klier, G. and Cheresh, D. A. (1994) Cell 79, 1157-1164.
16. Varner, J. A., Brooks, P. C. and Cheresh, D. A. (1995) Cell Adhes. Commun. 3, 367-374.
17. Varner, J.A.A. and Cheresh, D. A. (1996) in Important Advances in Oncology, eds. DeVita, V. T., Hellman, S. and Rosenberg, S. A. (Lippencott-Raven Publishers, Philadelphia).
18. Rusnati, M., Tanghetti, E., Dell'Era, P., Gualandris, A. and Presta. M. (1997) Mol. Biol. Cell 8, 2449-2461.
19. Brooks, P. C., Stromblad, S., Sanders, L.C., von Schalscha, T.L., Aimes, R.T., Stetlet-Stevenson, W.G., Quigley, J.P and Cheresh, D.A. (1996) Cell 85, 683-693.
20. Stromblad, S., Becker, J.C., Yebra, M., Brooks, P.C. and Cheresh, D. A. (1996) J. Clin. Invest. 98, 426-433.
21. Eliceiri, B. P. and Cheresh, D.A. (2001) Curr. Opin. Cell Biol. 13, 563-568.
22. Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. and Cheresh, D. (1995) J. Clin. Invest. 96, 1815-1822.
23. Brem, R. B., Robbins, S. G., Wilson, D. J., O'Rourke, L. M., Mixon, R. N., Robertson, J. E., Planck, S. R. and Rosenbaum, J. T. (1994) Invest. Ophthalmol. Vis. Sci. 35, 3466-3474.
24. Horton, M. A. (1997) Int. J. Biochem. Cell Biol. 29, 721-725.
25. Ross, F. P., Chappel, J., Alvarez, J. I., Sander, D., Butler, W. T., Farach-Carson, M. C., Mintz, K. A., Robey, P. G., Teilelbaum, S. L. and Cheresh, D. A. (1993) J. Biol. Chem. 268, 9901-9907.
26. Koch, A. E. (2000) Ann. Rheum. Dis. 59, 65-71.
27. Goldring, S.R. and Gravallese, E.M. (2000) Curr. Opin. Rheumatology 12, 195-199.
28. Albelda, S.M., Mette, S.A., Elder, D.E., Stewart, R., Damjanovich, L., Herlyn, M. and Buck CA. (1990) Cancer Res. 50, 6757-6764.
29. Gladson, C. and Cheresh, D.A. (1991) J. Clin. Inves. 88, 1924-1932.
30. Felding-habermann, B., Mueller, B.M., Romerdahl, C.A. and Cheresh, D.A (1992) J. Clin. Invest. 89, 2018-2022.
31. Chatterjee, S., Matsumura, A., Schradermeier, J. and Gillespie, G.Y. (2000) J. Neurooncol. 46, 135-144.
32. Ferrara, N. and Gerber, H.P. (2001) Acta Haematol. 106, 148-156.
33. Byzova, T. V., Goldman. C.K., Pampori, N., Thomas, K.A., Bett, A., Shattil, S.J., Plow, E.F. (2000) Mol. Cell 6, 851-860.
34. Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G. and Bussolino, F. (1999) EMBO J. 18, 882-892.
35. Borges, E., Jan, Y. and Ruoslahti, E. (2000) J. Biol. Chem. 275, 39867-39873.
36. Stupack, D. G., Puente, X.S., Boutsaboualoy, S., Storgard, C.M., Cheresh, D.A. (2001) J. Cell Biol. 155, 459-470.
37. Kumar, C. C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T., Varner, J., Liu, M., Smith, E.M., Neustadt, B., Presta, M. and Armstrong, L. (2001) Cancer Res. 61, 2232-2238.
38. Carron, C. P., Meyer, D.M., Pegg, J.A., Engleman, W., Nickols, M.A., Settle, S.L., Westlin, W.F., Ruminski, P.G. and Nickols, G.A. (1998) Cancer Research 58, 1930-1935.
39. Kerr, J. S., Wexler, R.S., Mousa, S.A., Robinson, C.S., Wexler, E.J., Mohamed, S., Voss, M.E., Devenny, J.J., Czerniak, P.M., Gudzelak, A. and Slee, A.M. (1999) Anticancer Res. 19, 959-968.
40. Friedlander, M., Theesfeld, C.T., Sugita, M., Fruttiger, M., Thomas, M.A., Chang, S. and Cheresh, D.A. (1995) Proc. Natl. Acad. Sci. USA 93, 9764-9769.
41. Mitjans, F., Sander, D., Adan, J., Sutter, A., Martinez, J.M., Jaggle, C.S., Moyano, J.M., Kreysch, H.G., Piulats, J. and Goodman, S.L. (1995) J. Cell Sci. 108, 2825-2838.
42. Montgomery, A. M., Reisfeld, R. A. and Cheresh, D. A. (1994) Proc. Natl. Acad. Sci. USA 91, 8856-8860.
43. Petitclerc, E., Stromblad, S., von Schalsck, T.L., Mitjans, F., Piulats, J., Montgomery, A.M.P., Cheresh, D.A and Brooks, P.A. (1999) Cancer Res. 59, 2724-2730.
44. Lode, H. N., Moehler, T., Xiang, R., Jonczyk, A., Gillies, S.D., Cheresh, D.A. and Reisfeld, R.A. (1999) Proc. Natl. Acad. Sci. USA 96, 1591-1596.
45. Storgard, C. M., Stupack, D.G., Jonczyk, A., Goodman, S.L., Fox, R.I. and Cheresh, D.A. (1999) J. Clin. Invest. 103, 47-54.
46. Friedlander, M., Brooks, P.C., Shaffer, R.W., Kincaid, C.M., Varner, J.A. and Cheresh, D.A. (1995) Science 270, 1500-1502.
47. Eliceiri, B. P. and Cheresh, D. A. (2000) Cancer J. Sci. Am. Suppl. 3, S245-249.
48. Gutheil, J. C., Campbell, T.N., Pierce, P.R., Watkins, J.D., Huse, W.D., Bodkin, D.J. and Cheresh, D.A. (2000) Clinical Cancer Res. 6, 3056-3061.
49. Gasparini, G., Brooks, P.C., Biganzoli, E., Vermeulen, P.B., Bonoldi, E., Dirix, L.Y., Ranieri, G., Miceli, R. and Cheresh, D.A. (1998) Clin. Cancer Res. 4, 2625-2634.
50. Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M.D. and Li, K. C. (1998) Nat. Med. 4(5), 623-626.
51. Pasqualini, R., Koivnem, E. and Ruoslahti, E. (1997) Nature Biotech. 15, 542-546.
52. Arap, W., Pasqualini, R. and Ruoslahti, E. (1998) Science 279, 377-380.
53. Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P. and Lejeune, J.F. (1998) Nature Med. 4, 408-414.
54. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C., Pihlajaniemi, T., Alitalo, K., Vuori, K. (2001) Proc. Natl. Acad. Sci. USA 98, 1024-1029.
55. Maeshima, Y., Sudhakar, A., Lively, J.C., Ueki, K., Kharbanda, S., Kahn, C.R., Sonenberg, N., Hynes, R.O. and Kalluri, R. (2002) Science 295, 140-143.
56. Carpizo, D. and Iruela-Arispe, M.L. (2000) Cancer Metastasis Rev. 19, 159-165.
57. Tarui, T., Miles, L.A. and Takada, Y. (2001) J. Biol. Chem. 276, 39562-39568.
58. Edlund, M., Miyamoto, T., Sikes, R.A., Ogle, R., Laurie, G.W., Farach-Carson, M.C., Otey, C.A., Zhau, H.E. and Chung, L. W. (2001) Cell Growth Differ. 12, 99-107.
59. Yaccoby, S., Pearse, R.N., Johnson, C.L., Barlogie, B. Choi, Y. and Epstein, J. (2002) Br. J. Haematol. 116, 278-290.
60. Hartman, G. D. and Duggan, M.E. (2000) Expert Opin. Investig. Drugs 9, 1281-1291.
61. Reynolds, L. E., Wyder, L., Lively, J.C., Taverna, D., Robinson, S.D., Huang, X., Sheppard, D., Hynes, R.O. and Hodivala-Dilke, K.M. (2002) Nat. Med. 8, 27-34.
62. Cheresh, D. A. and Stupack, D.G. (2002) Nat. Med. 8, 193-194.
63. Plath, T., Detjen, K., Welzel, M., von Marschall, Z., Murphy, D., Schirner, M., Wiedenmann, B. and Rosewicz, S. (2000) J. Cell Biol. 150, 1467-1478.
64. Kumar, C. C. and Armstrong, L. (2002) Integrin antagonists as Cancer therapeutics (Academic Press, San Diego).
65. Investigational drug data base. (2002) Current Drugs, Ltd. London, U.K.
66. Miller, W. H., Alberts, D.P., Bhatnagar, P.K., Bondinell, W.E., Callahan, J.F., Calvo, R.R., Cousins, R.D., Erhard, K. F., Heerding, D.A., Keenan, R.M., Kwon, C., Manley, P.J., Newlander, K.A., Ross, S.T., Samanen, J.M., Uzinskas, I.N., Venslavsky, J.W., Yuan, C.C., Haltiwanger, R.C., Gowen, M., Hwang, S.M., James, I.E., Lark, M.W., Rieman, D.J. and Stroup. G.B. (2000) J. Med. Chem. 43, 22-26.
67. Miller, W. H., Bondinell, W. E., Cousins, R. D., Erhard, K. F., Jakas, D. R., Keenan, R. M., Ku, T. W., Newlander, K. A., Ross, S.T., Haltiwanger, R.C., Bradbeer, J., Drake, F.H., Gowen, M., Hoffman, S.J., Hwang, S.M., James, I.E., Lark, M.W., Lechowska, B., Rieman, D.J., Stroup, G.B., Vasko-Moser, J. A., Zembryki, D.L., Azzarano, L.M., Adams, P.C. and Huffman, W. F. (1999) Bioorg. Med. Chem. Lett. 9, 1807-1812.
68. Coleman, K. R., Braden, G.A., Willingham, M.C. and Sane, D.C. (1999) Circ. Res. 84, 1268-1276.
69. Wu, H., Beuerlein, G., Nie, Y., Smith, H., Lee, B.A., Hensler, M., Huse, W.D. and Watkins, J.D. (1998) Proc. Natl. Acad. Sci USA 95, 6037-6042.